Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells

Journal of Immunology

Volumn 192, Issue 7, 2014, Pages 3029-3042

  Sasaki, Katsuhiro ^a   Bean, Angela ^a   Shah, Shivanee ^a   Schutten, Elizabeth ^a   Huseby, Priya G ^a   Peters, Bjorn ^b   Shen, Zu T ^a   Vanguri, Vijay ^a   Liggitt, Denny ^c   Huseby, Eric S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MYELIN ASSOCIATED GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; AUTOIMMUNITY; B LYMPHOCYTE; BRAIN DAMAGE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CELL INFILTRATION; CELL ISOLATION; CELL LINEAGE; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CONTROLLED STUDY; DISEASE SEVERITY; EFFECTOR CELL; FEMALE; GRAY MATTER; MALE; MESENCEPHALON; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; REMISSION; SPINAL CORD; WHITE MATTER;

ANIMALS; ASTROCYTES; AUTOIMMUNITY; BRAIN; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASES; FLOW CYTOMETRY; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; INTERFERON-GAMMA; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MICE, TRANSGENIC; MULTIPLE SCLEROSIS; RECEPTORS, ANTIGEN, T-CELL; SPINAL CORD;

EID: 84897568734     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302911     Document Type: Article

References (88)

1. Frohman, E. M., M. K. Racke, and C. S. Raine. 2006. Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med. 354: 942-955.
2. Lassmann, H., W. Brück, and C. F. Lucchinetti. 2007. The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17: 210-218.
3. Hafler, D. A., A. Compston, S. Sawcer, E. S. Lander, M. J. Daly, P. L. De Jager, P. I. de Bakker, S. B. Gabriel, D. B. Mirel, A. J. Ivinson, et al; International Multiple Sclerosis Genetics Consortium. 2007. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357: 851-862.
4. Sospedra, M., and R. Martin. 2005. Immunology of multiple sclerosis. Annu. Rev. Immunol. 23: 683-747.
5. Goverman, J. 2009. Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9: 393-407.
6. Kuchroo, V. K., A. C. Anderson, H. Waldner, M. Munder, E. Bettelli, and L. B. Nicholson. 2002. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20: 101-123.
7. Ercolini, A. M., and S. D. Miller. 2006. Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 176: 3293-3298.
8. Steinman, L. 2009. A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9: 440-447.
9. Rice, G. P., H. P. Hartung, and P. A. Calabresi. 2005. Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64: 1336-1342.
10. van Oosten, B. W., M. Lai, S. Hodgkinson, F. Barkhof, D. H. Miller, I. F. Moseley, A. J. Thompson, P. Rudge, A. McDougall, J. G. McLeod, et al. 1997. Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial. Neurology 49: 351-357.
11. Lindsey, J. W., S. Hodgkinson, R. Mehta, D. Mitchell, D. Enzmann, and L. Steinman. 1994. Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann. Neurol. 36: 183-189.
12. Booss, J., M. M. Esiri, W. W. Tourtellotte, and D. Y. Mason. 1983. Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62: 219-232.
13. Traugott, U., E. L. Reinherz, and C. S. Raine. 1983. Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J. Neuroimmunol. 4: 201-221.
14. Hauser, S. L., A. K. Bhan, F. Gilles, M. Kemp, C. Kerr, and H. L. Weiner. 1986. Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19: 578-587.
15. Babbe, H., A. Roers, A. Waisman, H. Lassmann, N. Goebels, R. Hohlfeld, M. Friese, R. Schröder, M. Deckert, S. Schmidt, et al. 2000. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192: 393-404.
16. Huseby, E. S., P. G. Huseby, S. Shah, R. Smith, and B. D. Stadinski. 2012. Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Front. Immunol. 3: 64.
17. Tsuchida, T., K. C. Parker, R. V. Turner, H. F. McFarland, J. E. Coligan, and W. E. Biddison. 1994. Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. USA 91: 10859-10863.
18. Dressel, A., J. L. Chin, A. Sette, R. Gausling, P. Höllsberg, and D. A. Hafler. 1997. Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159: 4943-4951.
19. Crawford, M. P., S. X. Yan, S. B. Ortega, R. S. Mehta, R. E. Hewitt, D. A. Price, P. Stastny, D. C. Douek, R. A. Koup, M. K. Racke, and N. J. Karandikar. 2004. High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103: 4222-4231.
20. Zang, Y. C., S. Li, V. M. Rivera, J. Hong, R. R. Robinson, W. T. Breitbach, J. Killian, and J. Z. Zhang. 2004. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172: 5120-5127.
21. Medana, I., M. A. Martinic, H. Wekerle, and H. Neumann. 2001. Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159: 809-815.
22. Healy, B. C., M. Liguori, D. Tran, T. Chitnis, B. Glanz, C. Wolfish, S. Gauthier, G. Buckle, M. Houtchens, L. Stazzone, et al. 2010. HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 75: 634-640.
23. Cree, B. A., J. D. Rioux, J. L. McCauley, P. A. Gourraud, P. Goyette, J. McElroy, P. De Jager, A. Santaniello, T. J. Vyse, P. K. Gregersen, et al; IMAGEN; IMSGC. 2010. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS ONE 5: e11296.
24. Huseby, E. S., D. Liggitt, T. Brabb, B. Schnabel, C. Ohlén, and J. Goverman. 2001. A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194: 669-676.
25. Sun, D., J. N. Whitaker, Z. Huang, D. Liu, C. Coleclough, H. Wekerle, and C. S. Raine. 2001. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166: 7579-7587.
26. Ford, M. L., and B. D. Evavold. 2005. Specificity, magnitude, and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35: 76-85.
27. Friese, M. A., K. B. Jakobsen, L. Friis, R. Etzensperger, M. J. Craner, R. M. McMahon, L. T. Jensen, V. Huygelen, E. Y. Jones, J. I. Bell, and L. Fugger. 2008. Opposing effects of HLA class I molecules in tuning autoreactive CD8+ T cells in multiple sclerosis. Nat. Med. 14: 1227-1235.
28. Anderson, A. C., R. Chandwaskar, D. H. Lee, J. M. Sullivan, A. Solomon, R. Rodriguez-Manzanet, B. Greve, R. A. Sobel, and V. K. Kuchroo. 2012. A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J. Immunol. 188: 2084-2092.
29. Koh, D. R., W. P. Fung-Leung, A. Ho, D. Gray, H. Acha-Orbea, and T. W. Mak. 1992. Less mortality but more relapses in experimental allergic encephalomyelitis in CD82/2 mice. Science 256: 1210-1213.
30. Jiang, H., S. I. Zhang, and B. Pernis. 1992. Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256: 1213-1215.
31. Kim, H. J., and H. Cantor. 2011. Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin. Immunol. 23: 446-452.
32. Ortega, S. B., V. P. Kashi, A. F. Tyler, K. Cunnusamy, J. P. Mendoza, and N. J. Karandikar. 2013. The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J. Immunol. 191: 117-126.
33. Jiang, H., and L. Chess. 2006. Regulation of immune responses by T cells. N. Engl. J. Med. 354: 1166-1176.
34. Chou, Y. K., P. Henderikx, R. E. Jones, B. Kotzin, G. A. Hashim, H. Offner, and A. A. Vandenbark. 1992. Human CD8+ T cell clone regulates autologous CD4+ myelin basic protein specific T cells. Autoimmunity 14: 111-119.
35. Zhang, J., R. Medaer, P. Stinissen, D. Hafler, and J. Raus. 1993. MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261: 1451-1454.
36. Correale, J., B. Lund, M. McMillan, D. Y. Ko, K. McCarthy, and L. P. Weiner. 2000. T cell vaccination in secondary progressive multiple sclerosis. J. Neuroimmunol. 107: 130-139.
37. Killestein, J., M. J. Eikelenboom, T. Izeboud, N. F. Kalkers, H. J. Adèr, F. Barkhof, R. A. Van Lier, B. M. Uitdehaag, and C. H. Polman. 2003. Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS. J. Neuroimmunol. 142: 141-148.
38. Harrington, C. J., A. Paez, T. Hunkapiller, V. Mannikko, T. Brabb, M. Ahearn, C. Beeson, and J. Goverman. 1998. Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8: 571-580.
39. Targoni, O. S., and P. V. Lehmann. 1998. Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187: 2055-2063.
40. Huseby, E. S., C. Ohlén, and J. Goverman. 1999. Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice. J. Immunol. 163: 1115-1118.
41. Klein, L., M. Klugmann, K. A. Nave, V. K. Tuohy, and B. Kyewski. 2000. Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6: 56-61.
42. Zhang, N., and M. J. Bevan. 2011. CD8(+) T cells: foot soldiers of the immune system. Immunity 35: 161-168.
43. Vanguri, V., C. C. Govern, R. Smith, and E. S. Huseby. 2013. Viral antigen density and confinement time regulate the reactivity pattern of CD4 T-cell responses to vaccinia virus infection. Proc. Natl. Acad. Sci. USA 110: 288-293.
44. Shen, Z. T., M. A. Brehm, K. A. Daniels, A. B. Sigalov, L. K. Selin, R. M. Welsh, and L. J. Stern. 2010. Bi-specific MHC heterodimers for characterization of cross-reactive T cells. J. Biol. Chem. 285: 33144-33153.
45. Zhumabekov, T., P. Corbella, M. Tolaini, and D. Kioussis. 1995. Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice. J. Immunol. Methods 185: 133-140.
46. Huseby, E. S., B. Sather, P. G. Huseby, and J. Goverman. 2001. Age-dependent T cell tolerance and autoimmunity to myelin basic protein. Immunity 14: 471-481.
47. Guyenet, S. J., S. A. Furrer, V. M. Damian, T. D. Baughan, A. R. La Spada, and G. A. Garden. 2010. A simple composite phenotype scoring system for evaluating mouse models of cerebellar ataxia. J. Vis. Exp. 39: 1787.
48. Zelenika, D., B. Grima, M. Brenner, and B. Pessac. 1995. A novel glial fibrillary acidic protein mRNA lacking exon 1. Brain Res. Mol. Brain Res. 30: 251-258.
49. Moran, A. E., K. L. Holzapfel, Y. Xing, N. R. Cunningham, J. S. Maltzman, J. Punt, and K. A. Hogquist. 2011. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208: 1279-1289.
50. Masopust, D., and J. M. Schenkel. 2013. The integration of T cell migration, differentiation and function. Nat. Rev. Immunol. 13: 309-320.
51. Wakim, L. M., A. Woodward-Davis, R. Liu, Y. Hu, J. Villadangos, G. Smyth, and M. J. Bevan. 2012. The molecular signature of tissue resident memory CD8 T cells isolated from the brain. J. Immunol. 189: 3462-3471.
52. Zelenika, D., B. Grima, and B. Pessac. 1993. A new family of transcripts of the myelin basic protein gene: expression in brain and in immune system. J. Neurochem. 60: 1574-1577.
53. Cornet, A., T. C. Savidge, J. Cabarrocas, W. L. Deng, J. F. Colombel, H. Lassmann, P. Desreumaux, and R. S. Liblau. 2001. Enterocolitis induced by autoimmune targeting of enteric glial cells: a possible mechanism in Crohn's disease? Proc. Natl. Acad. Sci. USA 98: 13306-13311.
54. Magnusson, F. C., R. S. Liblau, H. von Boehmer, M. J. Pittet, J. W. Lee, S. J. Turley, and K. Khazaie. 2008. Direct presentation of antigen by lymph node stromal cells protects against CD8 T-cell-mediated intestinal autoimmunity. Gastroenterology 134: 1028-1037.
55. Kojima, K., H. Wekerle, H. Lassmann, T. Berger, and C. Linington. 1997. Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. J. Neural Transm. Suppl. 49: 43-51.
56. Berger, T., S. Weerth, K. Kojima, C. Linington, H. Wekerle, and H. Lassmann. 1997. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system. Lab. Invest. 76: 355-364.
57. Perchellet, A., I. Stromnes, J. M. Pang, and J. Goverman. 2004. CD8+ T cells maintain tolerance to myelin basic protein by 'epitope theft'. Nat. Immunol. 5: 606-614.
58. Ji, Q., A. Perchellet, and J. M. Goverman. 2010. Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. Nat. Immunol. 11: 628-634.
59. Peterson, J. W., L. Bö, S. Mörk, A. Chang, and B. D. Trapp. 2001. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50: 389-400.
60. Calabrese, M., N. De Stefano, M. Atzori, V. Bernardi, I. Mattisi, L. Barachino, A. Morra, L. Rinaldi, C. Romualdi, P. Perini, et al. 2007. Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 64: 1416-1422.
61. Fisher, E., J. C. Lee, K. Nakamura, and R. A. Rudick. 2008. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann. Neurol. 64: 255-265.
62. Lucchinetti, C. F., B. F. Popescu, R. F. Bunyan, N. M. Moll, S. F. Roemer, H. Lassmann, W. Brück, J. E. Parisi, B. W. Scheithauer, C. Giannini, et al. 2011. Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365: 2188-2197.
63. Middeldorp, J., and E. M. Hol. 2011. GFAP in health and disease. Prog. Neurobiol. 93: 421-443.
64. Wong, G. H., P. F. Bartlett, I. Clark-Lewis, F. Battye, and J. W. Schrader. 1984. Inducible expression of H-2 and Ia antigens on brain cells. Nature 310: 688-691.
65. Nait-Oumesmar, B., N. Picard-Riera, C. Kerninon, L. Decker, D. Seilhean, G. U. Höglinger, E. C. Hirsch, R. Reynolds, and A. Baron-Van Evercooren. 2007. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc. Natl. Acad. Sci. USA 104: 4694-4699.
66. Linker, R. A., P. Brechlin, S. Jesse, P. Steinacker, D. H. Lee, A. R. Asif, O. Jahn, H. Tumani, R. Gold, and M. Otto. 2009. Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage. PLoS ONE 4: e7624.
67. Fissolo, N., S. Haag, K. L. de Graaf, O. Drews, S. Stevanovic, H. G. Rammensee, and R. Weissert. 2009. Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell. Proteomics 8: 2090-2101.
68. Standifer, N. E., Q. Ouyang, C. Panagiotopoulos, C. B. Verchere, R. Tan, C. J. Greenbaum, C. Pihoker, and G. T. Nepom. 2006. Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55: 3061-3067.
69. Schwab, N., C. G. Bien, A. Waschbisch, A. Becker, G. H. Vince, K. Dornmair, and H. Wiendl. 2009. CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 132: 1236-1246.
70. Kawakami, N., S. Lassmann, Z. Li, F. Odoardi, T. Ritter, T. Ziemssen, W. E. Klinkert, J. W. Ellwart, M. Bradl, K. Krivacic, et al. 2004. The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199: 185-197.
71. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
72. Pierson, E., S. B. Simmons, L. Castelli, and J. M. Goverman. 2012. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248: 205-215.
73. Klotz, L., and H. Wiendl. 2013. Monoclonal antibodies in neuroinflammatory diseases. Expert Opin. Biol. Ther. 13: 831-846.
74. Bettelli, E., D. Baeten, A. Jäger, R. A. Sobel, and V. K. Kuchroo. 2006. Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Deviclike disease in mice. J. Clin. Invest. 116: 2393-2402.
75. Pöllinger, B., G. Krishnamoorthy, K. Berer, H. Lassmann, M. R. Bösl, R. Dunn, H. S. Domingues, A. Holz, F. C. Kurschus, and H. Wekerle. 2009. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J. Exp. Med. 206: 1303-1316.
76. Fillatreau, S., C. H. Sweenie, M. J. McGeachy, D. Gray, and S. M. Anderton. 2002. B cells regulate autoimmunity by provision of IL-10. Nat. Immunol. 3: 944-950.
77. DiLillo, D. J., M. Horikawa, and T. F. Tedder. 2011. B-lymphocyte effector functions in health and disease. Immunol. Res. 49: 281-292.
78. Pierson, E. R., I. M. Stromnes, and J. M. Goverman. 2014. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system. J. Immunol. 192: 929-939.
79. Molnarfi, N., U. Schulze-Topphoff, M. S. Weber, J. C. Patarroyo, T. Prod'homme, M. Varrin-Doyer, A. Shetty, C. Linington, A. J. Slavin, J. Hidalgo, et al. 2013. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J. Exp. Med. 210: 2921-2937.
80. Rock, K. L., and L. Shen. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207: 166-183.
81. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous systeminfiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155.
82. Neumann, H., I. M. Medana, J. Bauer, and H. Lassmann. 2002. Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases. Trends Neurosci. 25: 313-319.
83. Jacobsen, M., S. Cepok, E. Quak, M. Happel, R. Gaber, A. Ziegler, S. Schock, W. H. Oertel, N. Sommer, and B. Hemmer. 2002. Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 125: 538-550.
84. Junker, A., J. Ivanidze, J. Malotka, I. Eiglmeier, H. Lassmann, H. Wekerle, E. Meinl, R. Hohlfeld, and K. Dornmair. 2007. Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 130: 2789-2799.
85. Liu, G. Z., L. B. Fang, P. Hjelmström, and X. G. Gao. 2007. Increased CD8+ central memory T cells in patients with multiple sclerosis. Mult. Scler. 13: 149-155.
86. Lees, J. R., P. T. Golumbek, J. Sim, D. Dorsey, and J. H. Russell. 2008. Regional CNS responses to IFN-gamma determine lesion localization patterns during EAE pathogenesis. J. Exp. Med. 205: 2633-2642.
87. Kamimura, D., M. Yamada, M. Harada, L. Sabharwal, J. Meng, H. Bando, H. Ogura, T. Atsumi, Y. Arima, and M. Murakami. 2013. The gateway theory: bridging neural and immune interactions in the CNS. Front. Neurosci. 7: 204.
88. Kang, Z., C. Z. Altuntas, M. F. Gulen, C. Liu, N. Giltiay, H. Qin, L. Liu, W. Qian, R. M. Ransohoff, C. Bergmann, et al. 2010. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 32: 414-425.